Jan 08, 2024 / 10:15PM GMT
Lisa Christine Gill - JPMorgan Chase & Co, Research Division - Analyst
Good afternoon and thank you for joining us. My name is Lisa Gill, and I am head of health care services here at JPMorgan. It's with great pleasure this afternoon that we have with us Surgery Partners. Presenting for Surgery Partners are Eric Evans, CEO. And then after Eric does the presentation, he's going to join myself and Dave Doherty for just some Q&A. So with that, let me turn it over to Eric.
J. Eric Evans - Surgery Partners, Inc. - CEO & Director
All right. Good afternoon and Happy New Year, everyone. My name is Eric Evans. I'm privileged to serve as the CEO of Surgery Partners. Delighted to always talk about the company. It's always a nice opportunity. I would just, before I get started, mention that we did prerelease this morning reiterating our 2023 guidance and providing an earnings at least of or better than $495 million adjusted EBITDA next year. So in case you missed that, just wanted to make sure I said that. Also, I'm going to do my best to say relatively short on
Surgery Partners, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 02:15 PM Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers